NO983970D0 - Tricykliske forbindelser, deres fremstilling og anvendelse - Google Patents
Tricykliske forbindelser, deres fremstilling og anvendelseInfo
- Publication number
- NO983970D0 NO983970D0 NO983970A NO983970A NO983970D0 NO 983970 D0 NO983970 D0 NO 983970D0 NO 983970 A NO983970 A NO 983970A NO 983970 A NO983970 A NO 983970A NO 983970 D0 NO983970 D0 NO 983970D0
- Authority
- NO
- Norway
- Prior art keywords
- group
- optionally substituted
- substituted hydrocarbon
- amino
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/94—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/70—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with ring systems containing two or more relevant rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/052—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being six-membered
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Anesthesiology (AREA)
- Diabetes (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Furan Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pyrane Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP5149196 | 1996-03-08 | ||
JP18366796 | 1996-07-12 | ||
JP2918597 | 1997-02-13 | ||
PCT/JP1997/000677 WO1997032871A1 (en) | 1996-03-08 | 1997-03-05 | Tricyclic compounds, their production and use |
Publications (3)
Publication Number | Publication Date |
---|---|
NO983970L NO983970L (no) | 1998-08-28 |
NO983970D0 true NO983970D0 (no) | 1998-08-28 |
NO322205B1 NO322205B1 (no) | 2006-08-28 |
Family
ID=27286462
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO19983970A NO322205B1 (no) | 1996-03-08 | 1998-08-28 | Tricykliske forbindelser, deres fremstilling og anvendelse samt preparater inneholdende forbindelsene |
Country Status (20)
Country | Link |
---|---|
US (1) | US6218429B1 (no) |
EP (2) | EP1550655A1 (no) |
JP (1) | JP4358917B2 (no) |
KR (1) | KR100494214B1 (no) |
CN (3) | CN100441574C (no) |
AT (1) | ATE219071T1 (no) |
CA (1) | CA2241666C (no) |
CZ (1) | CZ291626B6 (no) |
DE (1) | DE69713294T3 (no) |
DK (1) | DK0885210T5 (no) |
ES (1) | ES2175350T5 (no) |
HK (1) | HK1087112A1 (no) |
HU (1) | HU224220B1 (no) |
NO (1) | NO322205B1 (no) |
NZ (1) | NZ330656A (no) |
PL (1) | PL188093B1 (no) |
PT (1) | PT885210E (no) |
SK (1) | SK283970B6 (no) |
TW (1) | TW562803B (no) |
WO (1) | WO1997032871A1 (no) |
Families Citing this family (55)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2773798B1 (fr) * | 1998-01-16 | 2001-02-02 | Adir | Nouveaux composes tricycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
AU4060599A (en) * | 1998-06-09 | 1999-12-30 | Takeda Chemical Industries Ltd. | Pharmaceutical composition for treating or preventing sleep disorders |
CA2382418A1 (en) | 1999-08-20 | 2001-03-01 | Shigenori Ohkawa | Dihydrobenzofuran derivatives, process for preparing thereof and agents |
WO2001013950A1 (fr) | 1999-08-20 | 2001-03-01 | Takeda Chemical Industries, Ltd. | Agents d'absorption percutanee |
JP4632499B2 (ja) * | 1999-08-26 | 2011-02-16 | 武田薬品工業株式会社 | 鼻粘膜付着マトリックス |
BR0013848A (pt) * | 1999-09-08 | 2002-05-14 | Aventis Cropscience Uk Ltd | Composições herbicidas |
WO2002040053A1 (fr) * | 2000-11-17 | 2002-05-23 | Takeda Chemical Industries, Ltd. | Preparation pharmaceutique contenant du talc/ du sulfate de baryum |
WO2002040054A1 (fr) * | 2000-11-17 | 2002-05-23 | Takeda Chemical Industries, Ltd. | Preparation pharmaceutique contenant de la copolyvidone |
US6800648B2 (en) | 2001-04-26 | 2004-10-05 | Wyeth | Antipsychotic aminomethyl derivatives of 7,8-dihydro-3H-1,6,9-trioxa-3-AZA-cyclopenta[a]naphthalen-2-one |
IL149377A (en) * | 2002-04-28 | 2012-10-31 | Neurim Pharma 1991 | Pharmaceutical formulation comprising melatonin for the potentiation of the effect of hypnotic compounds |
TW200626137A (en) * | 2004-12-13 | 2006-08-01 | Takeda Pharmaceuticals Co | Preventive or therapeutic agent for sleep disorder |
ZA200708445B (en) * | 2005-04-04 | 2009-03-25 | Takeda Pharmaceutical | Preventive or remedy for depression or anxiety neurosis |
ES2366381T3 (es) * | 2005-06-22 | 2011-10-19 | Takeda Pharmaceutical Company Limited | Comprimido que contiene un ingrediente activo difícilmente soluble. |
BRPI0614701A2 (pt) | 2005-07-29 | 2011-04-12 | Vanda Pharmaceuticals Inc | usos de um composto para melhorar a vigìlia e composições farmacêuticas |
WO2007108442A1 (ja) * | 2006-03-20 | 2007-09-27 | Takeda Pharmaceutical Company Limited | 過敏性腸症候群予防・治療薬 |
AR061478A1 (es) | 2006-06-19 | 2008-08-27 | Takeda Pharmaceutical | Compuesto triciclico y composicion farmaceutica |
US8273761B2 (en) | 2006-12-08 | 2012-09-25 | Takeda Pharmaceutical Company Limited | Tricyclic compound and medical use thereof |
WO2008083204A2 (en) * | 2006-12-28 | 2008-07-10 | Braincells, Inc. | Modulation of neurogenesis by melatoninergic ligands |
KR20090095666A (ko) * | 2006-12-28 | 2009-09-09 | 다케다 야쿠힌 고교 가부시키가이샤 | 삼환 화합물 및 이의 약학적 용도 |
EP2139845A1 (en) * | 2007-02-26 | 2010-01-06 | Teva Pharmaceutical Industries Ltd. | Intermediates and processes for the synthesis of ramelteon |
BRPI0810997A2 (pt) | 2007-04-26 | 2015-01-27 | Takeda Pharmaceutical | Composto, pró-droga, composição farmacêutica, método para prevenir ou tratar distúrbio do sono em um mamífero, e, uso do composto |
EP2098519A1 (en) | 2007-05-31 | 2009-09-09 | Teva Pharmaceutical Industries Ltd. | Process for the synthesis of ramelteon and its intermediates |
US20090105490A1 (en) * | 2007-07-12 | 2009-04-23 | Nurit Perlman | Polymorphic forms of ramelteon and processes for preparation thereof |
ES2324849A1 (es) * | 2007-10-25 | 2009-08-17 | Ferrer Internacional, S.A. | Compuestos de indano. |
US7470814B1 (en) * | 2007-10-31 | 2008-12-30 | Ferrer Internacional, S.A. | Process for the preparation of substituted 7-allyl-6-hydroxy-indanes |
US20090281176A1 (en) * | 2007-11-01 | 2009-11-12 | Vinod Kumar Kansal | Process for the synthesis of ramelteon and its intermediates |
EP2248808B1 (en) * | 2008-01-31 | 2014-07-16 | Takeda Pharmaceutical Company Limited | Prophylactic or therapeutic agent for attention deficit/hyperactivity disorder |
US8871807B2 (en) | 2008-03-28 | 2014-10-28 | Ecolab Usa Inc. | Detergents capable of cleaning, bleaching, sanitizing and/or disinfecting textiles including sulfoperoxycarboxylic acids |
AU2009230713C1 (en) | 2008-03-28 | 2018-08-02 | Ecolab Inc. | Sulfoperoxycarboxylic acids, their preparation and methods of use as bleaching and antimicrobial agents |
US8809392B2 (en) | 2008-03-28 | 2014-08-19 | Ecolab Usa Inc. | Sulfoperoxycarboxylic acids, their preparation and methods of use as bleaching and antimicrobial agents |
EP2350088A1 (en) * | 2008-07-30 | 2011-08-03 | Ferrer Internacional, S.A. | 1,6-dihydro-2h-3-oxa-6-aza-as-indacene compounds |
WO2010045565A1 (en) * | 2008-10-16 | 2010-04-22 | Teva Pharmaceutical Industries Ltd. | Process for the synthesis of ramelteon and its intermediates |
US20110207949A1 (en) * | 2008-11-14 | 2011-08-25 | Watson Pharma Private Limited | Process for the preparation of ramelteon |
WO2010074753A1 (en) | 2008-12-23 | 2010-07-01 | Map Pharmaceuticals, Inc. | Inhalation devices and related methods for administration of sedative hypnotic compounds |
EP2396309A1 (en) | 2009-02-12 | 2011-12-21 | LEK Pharmaceuticals d.d. | Synthesis of (s)-n-ý2-(1,6,7,8-tetrahydro-2h-indeno-ý5,4-b¨furan-8-yl)ethyl¨propionamide |
WO2010103553A1 (en) * | 2009-03-10 | 2010-09-16 | Industriale Chimica S.R.L. | Process for the preparation of ramelteon |
EP2243775A1 (en) | 2009-04-07 | 2010-10-27 | LEK Pharmaceuticals d.d. | Synthesis of 1-(2,3-Dihydrobenzofuran-4-YL)ethanone as intermediate in the preparation of ramelteon |
CN102648192B (zh) * | 2009-09-29 | 2015-08-26 | 广州南沙龙沙有限公司 | 1,2,6,7-四氢-8h-茚并[5,4-b] 呋喃-8-酮的制备方法 |
WO2012035303A2 (en) | 2010-09-17 | 2012-03-22 | Cipla Limited Et Al | A novel process for synthesis of ramelteon, and key intermediates for the synthesis of ramelteon |
CN102321056B (zh) * | 2011-07-29 | 2014-05-14 | 宁波人健药业集团股份有限公司 | 一种合成雷美替胺的方法 |
CN102391220A (zh) * | 2011-10-10 | 2012-03-28 | 四川大学 | 三环乙醇类化合物及其制备方法和用途 |
US9321664B2 (en) | 2011-12-20 | 2016-04-26 | Ecolab Usa Inc. | Stable percarboxylic acid compositions and uses thereof |
BR112014020748B1 (pt) | 2012-03-30 | 2021-02-23 | Ecolab Usa Inc. | método de tratamento de águas, método de tratamento de uma fonte de água e composição aquosa de tratamento de água com atividade antimicrobiana |
AR091699A1 (es) | 2012-07-10 | 2015-02-25 | Astellas Pharma Inc | Derivado de indol carboxamida |
WO2014010603A1 (ja) | 2012-07-10 | 2014-01-16 | アステラス製薬株式会社 | 腹圧性尿失禁又は混合型尿失禁の治療又は予防用医薬組成物、及び該医薬組成物に含有される化合物のスクリーニング方法 |
CN103724357B (zh) * | 2012-10-11 | 2016-06-08 | 中国药科大学 | 一种3,4-二氢吡喃并[3,2-b]吲哚-2-酮类化合物的合成方法 |
CN102924410A (zh) * | 2012-10-29 | 2013-02-13 | 华润赛科药业有限责任公司 | 一种雷美替胺的制备方法及其中间体 |
US8822719B1 (en) | 2013-03-05 | 2014-09-02 | Ecolab Usa Inc. | Peroxycarboxylic acid compositions suitable for inline optical or conductivity monitoring |
US10165774B2 (en) | 2013-03-05 | 2019-01-01 | Ecolab Usa Inc. | Defoamer useful in a peracid composition with anionic surfactants |
US20140256811A1 (en) | 2013-03-05 | 2014-09-11 | Ecolab Usa Inc. | Efficient stabilizer in controlling self accelerated decomposition temperature of peroxycarboxylic acid compositions with mineral acids |
PL3095781T3 (pl) | 2014-01-14 | 2019-01-31 | Astellas Pharma Inc. | Związek indolowy |
WO2017119456A1 (ja) | 2016-01-08 | 2017-07-13 | 武田薬品工業株式会社 | せん妄の予防または治療剤 |
KR20180100646A (ko) | 2016-01-08 | 2018-09-11 | 다케다 야쿠힌 고교 가부시키가이샤 | 자폐 스펙트럼 장애의 예방 또는 치료제 |
CN110776485B (zh) * | 2019-11-22 | 2022-09-30 | 山东邹平大展新材料有限公司 | 一种雷美替胺杂质的制备方法 |
WO2023059546A1 (en) * | 2021-10-04 | 2023-04-13 | Psilosterics, Llc | Serotonin receptor agonists and methods of making and using the same |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2680366B1 (fr) * | 1991-08-13 | 1995-01-20 | Adir | Nouveaux derives d'arylethylamines, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent. |
FR2681862B1 (fr) | 1991-09-27 | 1993-11-12 | Adir Cie | Nouvelles (benzocycloalkyl)alkylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent. |
FR2713636B1 (fr) | 1993-12-07 | 1996-01-05 | Adir | Nouveaux dérivés naphtaléniques, leur procédé de préparation, et les compositions pharmaceutiques qui les contiennent. |
GB9326192D0 (en) * | 1993-12-22 | 1994-02-23 | Glaxo Group Ltd | Chemical compounds |
GB9407919D0 (en) * | 1994-04-21 | 1994-06-15 | Glaxo Group Ltd | Chemical compounds |
FR2725985B1 (fr) † | 1994-10-21 | 1996-11-15 | Adir | Nouveaux composes tricycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
US5661186A (en) | 1995-02-24 | 1997-08-26 | Bristol-Myers Squibb Co. | Tetralinyl-and indanyl-ethylamides |
-
1997
- 1997-03-05 DE DE69713294T patent/DE69713294T3/de not_active Expired - Lifetime
- 1997-03-05 KR KR10-1998-0707080A patent/KR100494214B1/ko not_active IP Right Cessation
- 1997-03-05 CN CNB2005100916061A patent/CN100441574C/zh not_active Expired - Lifetime
- 1997-03-05 HU HU9900616A patent/HU224220B1/hu active IP Right Grant
- 1997-03-05 PL PL97328726A patent/PL188093B1/pl unknown
- 1997-03-05 SK SK1150-98A patent/SK283970B6/sk not_active IP Right Cessation
- 1997-03-05 CA CA002241666A patent/CA2241666C/en not_active Expired - Lifetime
- 1997-03-05 EP EP04027766A patent/EP1550655A1/en not_active Withdrawn
- 1997-03-05 DK DK97905450T patent/DK0885210T5/da active
- 1997-03-05 PT PT97905450T patent/PT885210E/pt unknown
- 1997-03-05 AT AT97905450T patent/ATE219071T1/de active
- 1997-03-05 ES ES97905450T patent/ES2175350T5/es not_active Expired - Lifetime
- 1997-03-05 CN CNA200610100063XA patent/CN1900067A/zh active Pending
- 1997-03-05 WO PCT/JP1997/000677 patent/WO1997032871A1/en active IP Right Grant
- 1997-03-05 CZ CZ19982775A patent/CZ291626B6/cs not_active IP Right Cessation
- 1997-03-05 NZ NZ330656A patent/NZ330656A/xx not_active IP Right Cessation
- 1997-03-05 CN CNB971927006A patent/CN100443480C/zh not_active Expired - Lifetime
- 1997-03-05 EP EP97905450A patent/EP0885210B2/en not_active Expired - Lifetime
- 1997-03-06 TW TW086102717A patent/TW562803B/zh not_active IP Right Cessation
-
1998
- 1998-08-28 NO NO19983970A patent/NO322205B1/no not_active IP Right Cessation
- 1998-09-22 JP JP26811098A patent/JP4358917B2/ja not_active Expired - Lifetime
-
1999
- 1999-05-10 US US09/309,519 patent/US6218429B1/en not_active Expired - Lifetime
-
2006
- 2006-06-28 HK HK06107304.0A patent/HK1087112A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO983970L (no) | Tricykliske forbindelser, deres fremstilling og anvendelse | |
NO800034L (no) | Nye (piperidinylalkyl)kinazolinderivater samt fremgangsmaate til deres fremstilling | |
ES2167371T3 (es) | Derivados de 1h-3-aril-pirrolidin-2,4-diona espirociclicos substituidos. | |
EA200602170A1 (ru) | Производные пиперидина, композиции на их основе, способы их применения | |
KR950704313A (ko) | 5-아릴인돌 유도체 및 세로토닌(5-ht₁)작용물질로서의 그의 용도(5-arylindole derivatives and their use as serotonin(5-ht₁)agonists) | |
DE69728544D1 (de) | Totalsynthese von acylfulvenen mit antitumorwirkung | |
BR9503536A (pt) | Composto processo para sua preparação seu uso e composição farmacêutica | |
ES2126075T3 (es) | Derivados biciclicos nitrogenados como inhibidores de la propil-endopeptidasa. | |
DE3776044D1 (de) | Pyridazinon-derivate. | |
ATE229996T1 (de) | Starkes grünstichiges gelbes disazopigment | |
FI893901A0 (fi) | Menetelmä tetrasyklisten masennuslääkkeiden valmistamiseksi | |
DE60017374D1 (de) | Antibakterielle mittel | |
EP1211253A4 (en) | DIHYDROBENZOFURAN TRICYCLIC DERIVATIVES, THEIR PREPARATION METHOD AND AGENTS | |
DE69004138T2 (de) | Mit einer Cyanogruppe substituierte Nitroanilin-Farbstoffe. | |
CO4370120A1 (es) | Tintas reactivas diazo, procesos para su preparacion y usos . | |
ATE462689T1 (de) | Vitamin-d-derivate mit substituenten an der 2- alpha-position | |
ATE340169T1 (de) | Herbizide 5-chlordifluormethyl-1, 3, 4-thiadiazol-2-yl-oxyacetanilide | |
WO2001064671A3 (fr) | Derives d'haloimidazole et leur utilisation en tant qu'antagonistes des recepteurs muscariniques m3 et serotoniques 5-ht4 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK1K | Patent expired |